Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry

Efficiency of COPD Case Finding Program by Spirometry in High-risk Customers of Urban Community Pharmacies

Status

UNKNOWN

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01576068

Acronym

FARMAEPOC

Enrollment

3600

Registered

2012-04-12

Start date

2010-10-31

Completion date

2013-06-30

Last updated

2012-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, Pharmacy, Spirometry, Case finding

Brief summary

Chronic Obstructive Pulmonary Disease (COPD) is a prevalent disease. In the investigators country, underdiagnosis has been estimated in around 80% of subjects. Early detection is done mainly in primary care but due to actual situation new alternatives have been proposed to decrease underdiagnosis. This present study promote by a multidisciplinary research team (respiratory medicine, primary care, nurse and pharmacist) raise the objective of evaluate the effect of a COPD case finding program guide by spirometry in community-pharmacies. From the results of a pilot-study conducted in 13 community-pharmacies in Barcelona, in which the investigators showed the feasibility of spirometry in community-pharmacies for the early detection of COPD, the investigators have design a second phase to evaluate the effect of this strategy. 100 Barcelona's community-pharmacies during 6 months will select high risk customers and will conduct a spirometry in agreement with the design protocol. 3600 spirometries is the establish objective. Participants hospitals will train pharmacist in spirometry and also control spirometry quality daily by a telematic pathway. Spirometry results will be evaluate in terms of effect and costs. The investigators will also evaluate the impact of this program in the health system by numbers of subjects diagnosed and follow up in primary care.

Interventions

OTHERSpirometry

Spirometry done in high-risk customers of community-pharmacies to detect airflow limitation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age over 40 years. * Current or former smoker * Chronic respiratory symptoms(cough, shortness of breath, expectoration)

Exclusion criteria

* Previous diagnosed chronic lung disease * Use of inhalers

Design outcomes

Primary

Measure	Time frame	Description
COPD Case Finding	During 15 months pharmacies will include subjects with possible COPD through spirometry.	Proportion of high-risk customers with spirometry showing a FEV1/FVC under 0,7.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026